Naoto Takahashi

Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial

Akira Tsuburaya, Kazuhiro Yoshida, Michiya Kobayashi et al. · The Lancet Oncology · 2014 · 108 citations

Oncology, Sequential Paclitaxel, Gastrointestinal Oncology +7

Sequence-dependent enhancement of cytotoxicity produced by ecteinascidin 743 (ET-743) with doxorubicin or paclitaxel in soft tissue sarcoma cells.

Naoto Takahashi, Wei Wei Li, Debabrata Banerjee et al. · PubMed · 2001 · 96 citations

Tumor Biology, Soft Tissue Sarcoma, Oncogenic Agent +14

Sensitivity of soft tissue sarcoma cell lines to chemotherapeutic agents: identification of ecteinascidin-743 as a potent cytotoxic agent.

Weiwei Li, Naoto Takahashi, S.C. Jhanwar et al. · PubMed · 2001 · 93 citations

Chemotherapeutic Agents, Tumor Biology, Medicine +13

Sentinel node mapping with indocyanine green (ICG) and infrared ray detection in early gastric cancer: An accurate method that enables a limited lymphadenectomy

Wendy Kelder, Hiroshi Nimura, Naoto Takahashi et al. · European Journal of Surgical Oncology · 2010 · 87 citations

Oncology, Sentinel Node, Medical Imaging +10

Sequence-dependent synergistic cytotoxicity of ecteinascidin-743 and paclitaxel in human breast cancer cell lines in vitro and in vivo.

Naoto Takahashi, Weiwei Li, Debabrata Banerjee et al. · PubMed · 2002 · 60 citations

Breast Oncology, Oncology, Potent Antitumor Agent +14